We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Von der Leyen confident bloc will hit goal of offering shots to 70% of adult population by end of summer
Pricing undermines Moscow’s claim that it is supplying poor countries with cheaper vaccines
Research provides scientific support for government’s road map out of lockdown
BioNTech’s vaccine facility in Marburg will produce 750m doses a year
Health ministry data show shot is 89% effective at preventing infection of any kind
New stability data come as Israel study shows efficacy of single dose
Covid-19 jab still works but produces only a third of the antibodies it did for original virus, study finds
Belated inoculation drive means not many will be immunised when games start in July
GlaxoSmithKline, Merck and Sanofi are left playing catch-up to upstarts with new technology
Early data need confirmation but government push to extend gap between jabs receives a boost
FT tracker shows rapid growth in doses administered around world — but warnings come of long road ahead
Drugmaker raises guidance for 2021 as it benefits from having one of the first shots approved
Von der Leyen vows BioNTech/Pfizer orders from Belgium will not be disrupted during tense call with Johnson
More transparency on pharmaceutical deals is needed but an export ban is not
Statistics show more than 90 per cent of recipients had major response to first jab
Despite the crop of vaccines, the healthcare industry expects to fight coronavirus for years
Delivery around the world is a new line of potential business
European officials say supply changes after ruling on doses per vial could derail vaccination plans
Laboratory-based study shows mutations were neutralised by antibodies in blood of vaccinated patients
Rich nations accused of not doing enough to ensure supply of Covid-19 jabs to poor countries
Drugmaker blames temporary cutback on factory revamp designed to boost production this year
Official document suggests enough doses for 500,000 jabs a day by next week
New manufacturing capacity will help increase 2021 production to 2bn shots
Sandra Gallina denies wrong products have been bought and says member states remain committed to joint action
Order for further 300m doses follows regulatory advice that additional dose can be extracted from each vial
International Edition
